Physician

Mohammed Dawood, M.D.

According to 2025 Medicare claims, Mohammed Dawood, M.D. (NPI: 1174589576) practices nephrology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is DECATUR MEMORIAL HOSPITAL (NPI: 1164477725; TIN: 370661199) and primary practice location at 62526-4162. Dawood is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Dawood's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 515 traditional Medicare patients, billed 1,784 HCPCS/CPT codes, and received $181,113 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,911 prescription claims across 283 beneficiaries totaling $371,272 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). Open Payments data shows 1 records totaling $3. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $295,382 to $181,113. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $650,430 to $371,272. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	788	3,884	$295,382
2016	896	4,028	$334,746
2017	869	3,766	$326,365
2018	855	3,724	$310,596
2019	850	3,694	$302,537
2020	706	2,865	$260,626
2021	773	2,714	$286,395
2022	644	2,149	$229,817
2023	548	1,725	$188,896
2024	515	1,784	$181,113

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	373	4,040	$650,430
2016	397	3,982	$820,985
2017	391	3,541	$970,304
2018	361	3,104	$627,467
2019	349	2,753	$537,569
2020	328	2,455	$436,124
2021	354	2,481	$389,197
2022	338	2,287	$333,609
2023	286	1,909	$422,693
2024	283	1,911	$371,272

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	51	51	$133
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	69	85	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	298	521	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	155	473	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	135	145	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	21	930	$113,800
Veltassa	Patiromer Calcium Sorbitex	62	2,245	$77,380
Lokelma	Sodium Zirconium Cyclosilicate	46	1,380	$36,073
Sevelamer Carbonate	Sevelamer Carbonate	52	2,701	$22,136
Jardiance	Empagliflozin	15	1,230	$18,182

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$3	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammed Dawood, M.D.?

Tedicare shows public-source Medicare data for Mohammed Dawood, M.D. (NPI 1174589576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed Dawood, M.D. have ACO affiliation data?

Mohammed Dawood, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Mohammed Dawood, M.D.?

Mohammed Dawood, M.D. is linked to DECATUR MEMORIAL HOSPITAL (billing NPI 1164477725) in the available physician profile data.

Does Mohammed Dawood, M.D. have Open Payments data?

Mohammed Dawood, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.